Bart Kiemeney will step down as director of the Radboud Institute for Health Sciences (RIHS) on 1 April. Bart has held this position for over seven years and has brought the quality of science Radboudumc-wide to a higher level. The Board of Directors is very grateful to him for his tireless efforts for high-quality and socially relevant health (care) research.After 1 April Bart will again focus on conducting his own research within his area of expertise and on teaching. We would like to give you the opportunity to say goodbye to Bart as director of the institute during the Radboud Research Round with theme Urological Cancers.
Thursday 28 March 2019
16.00 - 17.00 hrs Radboud Research Round Theme Urological cancers
17.00 - 17.15 hrs Looking back by Paul Smits and Bart Kiemeney
17.15 - 18.30 hrs Research Café
Your presence will be highly appreciated! Please send an e-mail to firstname.lastname@example.org if you want to be present.
Related news items
Step-up approach vs open necrosectomy for necrotizing pancreatitis18 April 2019
Another publication of the successful Dutch collaborative group on pancreatitis research with substantial contribution from Radboudumc researchers, Harry van Goor and Kees van Laarhoven.read more
Prophylactic antibiotics reduce hospitalisations and cost in head and neck cancer patients18 April 2019
In European journal of cancer Janneke Ham and colleagues showed that prophylactic antibiotics in locally advanced head and neck cancer patients treated with chemoradiotherapy did not reduce the incidence of (aspiration) pneumonias, but did reduce hospitalisations and tended to be cost-effective.read more
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more